Skip to content

COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery

COVID19-OR (SARS-CoV-2):Observation, Risk & Recovery. An Observational Study Exploring Risk Assessment and Recovery From COVID-19 (SARS-CoV-2) Infection in Hospitalised Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04524520
Enrollment
194
Registered
2020-08-24
Start date
2020-05-05
Completion date
2022-06-08
Last updated
2022-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients

Brief summary

A novel coronavirus, designated corona virus disease 2019 (COVID-19) has resulted in a Pandemic at the time of writing (27th April) the reported number of confirmed cases exceeding 3 million and over 200000 associated deaths. The burden on global critical care has been considerable. As of 24th April there have been 8752 UK critical care admissions with services under considerable strain, and a mortality rate over 50%. Survivors of critical illness will require significant input. This study will perform mixed methods to provide rich data on risk stratification and recovery from critical illness. Recovery from a novel disease requires documenting and the study reports physical and psychological changes following hospital discharge in survivors. In addition qualitative interviews are being conducted with patients who have survived and been discharged from critical care along with their relatives and treating professionals, to better understand their needs during recovery.

Interventions

None listed

Sponsors

Western Sussex Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults ≥18 years admitted to ICU with SARS-CoV-2 and survived 2. Relatives or friends and professionals involved in the care of these patients.

Exclusion criteria

1. Patients \<18 years; 2. Patients with a negative test for SARS-CoV-2 or patients not tested due to absence of symptoms;

Design outcomes

Primary

MeasureTime frameDescription
Physicalthrough study completion , an average of 1 yearChelsea critical care physical assessment tool
Health Related Quality of lifeat 3 monthsShort Form Survey on health related quality of life (SF-12). Two summary scores are reported from the SF-12 - a mental component score (MCS-12) and a physical component score (PCS-12). The scores may be reported as Z-scores (difference compared to the population average, measured in standard deviations). The United States population average PCS-12 and MCS-12 are both 50 points. Higher scores indicate better outcome.
Psychologicalthrough study completion , an average of 1 yearDepression Test Questionnaire (PHQ-9). Scores range from 1 to 27 and higher scores indicate worse outcome.

Secondary

MeasureTime frameDescription
risk stratificationthrough study completion and average of 1 yearescalation to critical care (Yes/No)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026